RARE DISEASES A–Z · LETTER H
Hereditary Spastic Paraplegia
Hereditary spastic paraplegia (HSP) is a group of inherited conditions — dozens of genes, one shared effect: the longest nerve fibres of the spinal cord, those carrying movement signals to the legs, gradually fail. The result is progressive stiffness and weakness that is almost entirely confined to the legs.
By Dr. Mohamed Ibrahim, MD, PhD — Assistant Professor of Medicine, Transplant Nephrology, University of Maryland School of Medicine · Last reviewed: November 2026
Rare Diseases A–Z is part of the MedicalVideos.com education program. It is produced independently of sponsors, and any future sponsorship will be labelled on the hub.
The guide
The basics
Movement commands travel from the brain down the corticospinal tracts — the longest nerve fibres in the body, up to a metre in length. In HSP the far ends of these fibres, which serve the legs, gradually degenerate, so signals weaken and the normal braking on reflexes is lost: legs become stiff (spastic) as well as weak. The bladder is often involved for the same reason, causing urgency and frequency. Arm involvement is usually mild. Onset ranges from early childhood to late adulthood depending on the gene — more than 80 HSP genes are known. 'Pure' HSP affects only the legs and bladder; 'complicated' forms add features such as learning difficulties, epilepsy, peripheral nerve damage, or thinning of the corpus callosum on brain scans.
How it works
The examination pattern — spastic, weak legs with brisk reflexes and upgoing toes, but normal or near-normal arms — points to the spinal cord pathways rather than the cord being compressed, though MRI of the spine is still done to exclude compression and other structural causes that can mimic HSP and are treatable. Brain imaging is added when complicated features are present. Genetic testing with a panel of HSP genes identifies the cause in many families; the commonest single cause in dominant families is SPG4 (spastin). A confirmed gene result allows testing of relatives and sharpens prognosis. When no gene is found, the diagnosis remains clinical, and periodic review keeps acquired mimics under consideration.
Day to day
No treatment yet halts the degeneration, so care is expert symptom management — and it makes a real difference. Daily stretching and physiotherapy maintain length in spastic muscles and preserve walking. Anti-spasticity medicines (such as baclofen or tizanidine tablets) reduce stiffness; botulinum toxin injections target specific overactive muscles; and for severe cases an implanted baclofen pump delivers the drug directly around the spinal cord. Orthotics stabilise ankles, walking aids extend range, and selected tendon surgery helps fixed contractures. Bladder spasticity is managed with medicines and, where needed, urology input. Many people remain walking for decades; the condition does not affect life expectancy in its pure form. Gene-specific research, including for SPG4, is under way.
When to get help
Reviews focus on walking, spasticity burden, bladder and bowel function, pain, and mood. Bladder symptoms deserve active management — infection risk rises if emptying is poor, so report urinary infections, retention, or new incontinence. Skin over the feet and any pressure areas need watching as mobility changes. Because progression is slow, equipment and home adaptations can be planned calmly ahead of need. Genetic counselling supports decisions about testing children and planning pregnancies. Seek prompt assessment for sudden worsening — HSP moves slowly, so a step-change usually means something else, such as a urinary infection, constipation, or a new spinal problem, has been added.
Common questions
What do 'pure' and 'complicated' HSP mean?
It is 'pure' when stiffness and weakness of the legs are the whole picture. It is 'complicated' or 'complex' when other features join in — such as thinning of the brain's connecting band, learning difficulties, epilepsy, nerve damage in the hands and feet, or eye problems — which usually reflects a different gene.
Can it vary a lot within one family?
Yes. In the commonest dominant form (SPG4), a parent with the gene change may have obvious spasticity, mild stiffness noticed only on examination, or occasionally nothing at all, while their child is more clearly affected. Severity does not reliably predict the next generation's.
Does HSP shorten life?
In typical adult-onset pure HSP, lifespan is normal — the condition affects mobility, not vital organs. Complicated forms vary by gene, and some childhood forms have wider effects, which is why identifying the type matters for prognosis.
Is there a cure on the horizon?
There is no treatment that stops the axon degeneration yet, though research is active. What exists is effective symptom management: spasticity medicines, botulinum toxin, physiotherapy, and in selected cases a baclofen pump or orthopaedic surgery — together these can substantially improve walking and comfort.
More in Letter H
Related
Sources
- Hereditary Spastic Paraplegia (National Organization for Rare Disorders (NORD))
- Hereditary Spastic Paraplegia — Genetic and Rare Diseases Information Center (NIH GARD)
- Hereditary Spastic Paraplegia (NINDS)
This guide is general information, not medical advice. Rare diseases are individual — diagnosis and treatment depend on your own results, other conditions, and treatment history, and are set by your treating team. Never start, stop, or change a medicine because of something you read here. If you have severe breathlessness, uncontrolled bleeding, confusion, sudden weakness, or thoughts of harming yourself, seek urgent care. Spasticity treatment and mobility planning are individual; follow your neurology team's advice.